450 related articles for article (PubMed ID: 25847503)
1. Autologous platelet-rich gel for treatment of diabetic chronic refractory cutaneous ulcers: A prospective, randomized clinical trial.
Li L; Chen D; Wang C; Yuan N; Wang Y; He L; Yang Y; Chen L; Liu G; Li X; Ran X
Wound Repair Regen; 2015; 23(4):495-505. PubMed ID: 25847503
[TBL] [Abstract][Full Text] [Related]
2. [Impact of topical application of autologous platelet-rich gel on medical expenditure and length of stay in hospitals in diabetic patients with refractory cutaneous ulcers].
Li L; Wang C; Wang Y; He LP; Yang YZ; Chen LH; Chen DW; Li XJ; Ran XW
Sichuan Da Xue Xue Bao Yi Xue Ban; 2012 Sep; 43(5):762-5. PubMed ID: 23230756
[TBL] [Abstract][Full Text] [Related]
3. Autologous platelet-rich gel treatment for diabetic chronic cutaneous ulcers: A meta-analysis of randomized controlled trials.
Li Y; Gao Y; Gao Y; Chen D; Wang C; Liu G; Yang X; Ran X
J Diabetes; 2019 May; 11(5):359-369. PubMed ID: 30182534
[TBL] [Abstract][Full Text] [Related]
4. [Dynamic changes of MMP-1, MMP-9 and TIMP-1 in the refractory diabetic dermal ulcers treated by autologous Platelet-rich gel].
He LP; Wang C; Chen DW; Li XJ; Ran XW
Sichuan Da Xue Xue Bao Yi Xue Ban; 2012 Sep; 43(5):757-61. PubMed ID: 23230755
[TBL] [Abstract][Full Text] [Related]
5. [Application of autologous platelet-rich gel to refractory chronic diabetic cutaneous ulcers].
Yuan N; Ran X
Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi; 2007 Apr; 21(4):426-9. PubMed ID: 17546893
[TBL] [Abstract][Full Text] [Related]
6. [The preliminary application of autologous platelet-rich gel used to treat refractory diabetic dermal ulcer].
Yuan NB; Wang C; Wang Y; Yu TT; Shu SQ; Liu M; Ran XW
Sichuan Da Xue Xue Bao Yi Xue Ban; 2007 Sep; 38(5):900-3. PubMed ID: 17953386
[TBL] [Abstract][Full Text] [Related]
7. [Preparation of autologous platelet-rich gel for diabetic refractory dermal ulcer and growth factors analysis from it].
Yuan N; Wang C; Wang Y; Yu T; Long Y; Zhang X; Ran X
Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi; 2008 Apr; 22(4):468-71. PubMed ID: 18575451
[TBL] [Abstract][Full Text] [Related]
8. [Study on the mechanism of autologous platelet-rich gel to treat the refractory diabetic dermal ulcers].
Yuan NB; Long Y; Zhang XX; Ran XW
Sichuan Da Xue Xue Bao Yi Xue Ban; 2009 Mar; 40(2):292-4. PubMed ID: 19462910
[TBL] [Abstract][Full Text] [Related]
9. Autologous Platelet-Rich Gel for the Treatment of Diabetic Sinus Tract Wounds: A Clinical Study.
Xie J; Fang Y; Zhao Y; Cao D; Lv Y
J Surg Res; 2020 Mar; 247():271-279. PubMed ID: 31706541
[TBL] [Abstract][Full Text] [Related]
10. Systematic reviews of wound care management: (3) antimicrobial agents for chronic wounds; (4) diabetic foot ulceration.
O'Meara S; Cullum N; Majid M; Sheldon T
Health Technol Assess; 2000; 4(21):1-237. PubMed ID: 11074391
[TBL] [Abstract][Full Text] [Related]
11. Platelet-Rich Plasma for the Treatment of Clean Diabetic Foot Ulcers.
Ahmed M; Reffat SA; Hassan A; Eskander F
Ann Vasc Surg; 2017 Jan; 38():206-211. PubMed ID: 27522981
[TBL] [Abstract][Full Text] [Related]
12. Beta-adrenergic antagonist for the healing of chronic diabetic foot ulcers: study protocol for a prospective, randomized, double-blinded, controlled and parallel-group study.
Kaur R; Tchanque-Fossuo C; West K; Hadian Y; Gallegos A; Yoon D; Ismailyan L; Schaefer S; Dahle SE; Isseroff RR
Trials; 2020 Jun; 21(1):496. PubMed ID: 32513257
[TBL] [Abstract][Full Text] [Related]
13. Management of chronic diabetic foot ulcers using platelet-rich plasma.
Babaei V; Afradi H; Gohardani HZ; Nasseri F; Azarafza M; Teimourian S
J Wound Care; 2017 Dec; 26(12):784-787. PubMed ID: 29244965
[TBL] [Abstract][Full Text] [Related]
14. A prospective, randomized, controlled trial of autologous platelet-rich plasma gel for the treatment of diabetic foot ulcers.
Driver VR; Hanft J; Fylling CP; Beriou JM;
Ostomy Wound Manage; 2006 Jun; 52(6):68-70, 72, 74 passim. PubMed ID: 16799184
[TBL] [Abstract][Full Text] [Related]
15. Outcomes Following Advanced Wound Care for Diabetic Foot Ulcers: A Canadian Study.
Roth-Albin I; Mai SHC; Ahmed Z; Cheng J; Choong K; Mayer PV
Can J Diabetes; 2017 Feb; 41(1):26-32. PubMed ID: 27634016
[TBL] [Abstract][Full Text] [Related]
16. A Prospective, Randomized, Blinded, Controlled Trial Comparing Transdermal Continuous Oxygen Delivery to Moist Wound Therapy for the Treatment of Diabetic Foot Ulcers.
Driver VR; Reyzelman A; Kawalec J; French M
Ostomy Wound Manage; 2017 Apr; 63(4):12-28. PubMed ID: 28448266
[TBL] [Abstract][Full Text] [Related]
17. Topical wound oxygen therapy in the treatment of severe diabetic foot ulcers: a prospective controlled study.
Blackman E; Moore C; Hyatt J; Railton R; Frye C
Ostomy Wound Manage; 2010 Jun; 56(6):24-31. PubMed ID: 20567051
[TBL] [Abstract][Full Text] [Related]
18. Randomised controlled clinical trial for autologous fibroblast-hyaluronic acid complex in treating diabetic foot ulcers.
You HJ; Han SK; Rhie JW
J Wound Care; 2014 Nov; 23(11):521-2, 524, 526-30. PubMed ID: 25375400
[TBL] [Abstract][Full Text] [Related]
19. Efficacy and safety of platelet-rich plasma in treating cutaneous ulceration: A meta-analysis of randomized controlled trials.
Shen Z; Zheng S; Chen G; Li D; Jiang Z; Li Y; Huang F
J Cosmet Dermatol; 2019 Apr; 18(2):495-507. PubMed ID: 30912259
[TBL] [Abstract][Full Text] [Related]
20. Effectiveness of autologous platelet-rich plasma gel in the treatment of hard-to-heal leg ulcers: a randomised control trial.
Rainys D; Cepas A; Dambrauskaite K; Nedzelskiene I; Rimdeika R
J Wound Care; 2019 Oct; 28(10):658-667. PubMed ID: 31600109
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
